Take a look at the links below to see Artios’ press coverage following our Novartis collaboration.
Endpoints |
Novartis taps DNA damage specialist Artios in $1.3B discovery deal to complement growing radioligand portfolio |
BioWorld |
Artios, Novartis combining DDR approach with radioligands in three-year, $1.3B deal |
BioCentury |
Artios adds to financial runway via radioligand target deal with Novartis |
GEN |
Novartis, Artios Pharma Target Cancer in Up-to-$1.3B DDR Collaboration |
|
Novartis taps Artios for targets to enhance radioligand drugs |
Pharmaphorum |
Novartis expands in radio-oncology again with $1.3bn Artios alliance |
The Pharma Letter |
Artios links up with Novartis on DDR cancer therapies |
Pharma Times |
Artios, Novartis form cancer therapies collaboration |
Pharmafile |
Novartis and Artios Pharma to collaborate on DDR cancer therapies |
PharmaShots |
Novartis Collaborates with Artios Pharma to Discover Next Generation DDR Cancer Therapies |
Benzinga |
Novartis Taps Artios In Discovery Pact To Enhance Radioligand Portfolio |
Awp |
Novartis baut Onkologie-Pipeline über Zusammenarbeit mit Artios Pharma aus |
L’Agefi |
Novartis s’assure les services d’Artios pour se développer en oncologie |
Cash.ch |
Novartis baut Onkologie-Pipeline über Zusammenarbeit mit Artios Pharma aus |
Finanzen.ch |
Novartis baut Onkologie-Pipeline über Zusammenarbeit mit Artios Pharma aus – Aktie dennoch rot |
Bilan |
Novartis s’assure les services d’Artios pour se développer en oncologie |
Marketscreener |
Novartis baut Onkologie-Pipeline über Zusammenarbeit mit Artios Pharma aus |
Investfeed |
Novartis expands oncology pipeline through collaboration with Artios Pharma |
Tradedirect |
Novartis baut Onkologie-Pipeline über Zusammenarbeit mit Artios Pharma aus |
VOX Markets |
Arix’s Artios Pharma enters global research collaboration with Novartis |
Biospace |
Artios, Novartis Aim to Develop and Discover DDR Targets for Cancer in New Partnership |
Oncologie : Novartis va collaborer avec Artios Pharma |